Pathway Financial Advisers’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-440
Closed -$124K 289
2025
Q3
$124K Buy
+440
New +$112K 0.04% 179
2025
Q1
Sell
-437
Closed -$72.7K 335
2024
Q4
$72.7K Buy
437
+2
+0.5% +$355 0.02% 209
2024
Q3
$74.2K Hold
435
0.03% 165
2024
Q2
$61.3K Buy
435
+3
+0.7% +$373 0.02% 214
2024
Q1
$54.3K Buy
432
+1
+0.2% +$114 0.02% 222
2023
Q4
$45.4K Buy
431
+2
+0.5% +$218 0.02% 230
2023
Q3
$45.5K Buy
+429
New +$49.7K 0.02% 231
2023
Q1
$47.8K Buy
514
+1
+0.2% +$88 0.02% 238
2022
Q4
$41.9K Buy
+513
New +$39K 0.02% 255

Other funds holding ORCL

Pathway Financial Advisers's ORCL Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Oracle (ORCL) in Q4 2025, closing a stake of 440 shares — an estimated $124K sold.

Pathway Financial Advisers first reported a position in ORCL in Q4 2022 and held it in 9 quarters. The position peaked at $124K in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 440 Oracle shares in Q4 2025, an estimated $124K.
  • Pathway Financial Advisers first reported a position in Oracle in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's Oracle position peaked at $124K in Q3 2025.
  • 3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.